PUBLIC COMPANY
saveNeuraptive Therapeutics Inc
updated 13d ago
community read0 votes
pipeline
1
marketed
0
phase 3
1
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 3
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase3This Study Will Evaluate the Effectiveness of NTX-001, a Surgical Nerve Repair Product When Used in People With Upper Extremity Nerve Lacerations.
- —NTX-001 to Repair Peripheral Nerve Transection(s)
- phase2Safety and Efficacy of NTX-001 Compared to SOC in Acute Single Peripheral Nerve Injuries
- phase2A Study of NTX-001 in the Treatment and Prevention of Facial Paralysis Requiring Surgical Repair.
🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that